RP Bio Inc. (KOSDAQ:314140)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2017	Dec 31, 2016
Health Functional Food	71.86B
Health Functional Food Growth	-16.44%
Medicines	51.47B
Medicines Growth	-19.44%
Raw Materials, etc.	332.92M
Raw Materials, etc. Growth	-63.46%
Other	303.20M
Other Growth	19.92%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2017	Dec 31, 2016
South Korea	122.59B
South Korea Growth	-18.52%
Other	1.38B
Other Growth	128.34%

Data Source: Finnhub Last updated: Mar 31, 2026

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error